Bookmark and Share

Compound Summary for: CID 3171

Droxidopa

Also known as: 2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid; ST50437521; threo-Dopaserine; L-Threodops; Droxidopa [Latin]
Molecular Formula: C9H11NO5   Molecular Weight: 213.18734   InChIKey: QXWYKJLNLSIPIN-UHFFFAOYSA-N
A precursor of noradrenaline that is used in the treatment of parkinsonism. The racemic form (DL-threo-3,4-dihydroxyphenylserine) has also been used, and has been investigated in the treatment of orthostatic hypotension. There is a deficit of noradrenaline as well as of dopamine in Parkinson's disease and it has been proposed that this underlies the sudden transient freezing seen usually in advanced disease. Administration of DL-threo-3,4-dihydroxyphenylserine has been claimed to result in an improvement in this phenomenon but controlled studies have failed to demonstrate improvement. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)   From: MeSH
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Use and Manufacturing
Pharmacology
Biomedical Effects and Toxicity
Literature
Patents
Biological Test Results
Classification
Chemical and Physical Properties
_ _